Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANDREW S BOYER Insider Profile
4 Followers
ANDREW S BOYER, EVP at Amneal Pharmaceuticals, holds 256.67K shares in Amneal Pharmaceuticals (Ticker: AMRX). Most recently, ANDREW S BOYER Sold $62,711 shares of Amneal Pharmaceuticals on Aug 16, 2024 for an estimated value of 491.38K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-27.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP
Roles that ANDREW S BOYER holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 07, 2019 - Aug 07, 2020
Return:+51.50%
The most profitable trade made by ANDREW S BOYER
ANDREW S BOYER's Trading History
List of latest transactions for each holding click on a transaction to see ANDREW S BOYER's performance on stock
You May Also Like
ANDREW S BOYER insider profile FAQ
What is the percentage of profitable transactions made by ANDREW S BOYER?
The percentage of profitable transactions made by ANDREW S BOYER is 25%.
What is the average return per transaction made by ANDREW S BOYER?
The average return per transaction made by ANDREW S BOYER is -27.20%.
What stocks does ANDREW S BOYER hold?
ANDREW S BOYER holds: AMRX stocks.
What was ANDREW S BOYER’s latest transaction?
ANDREW S BOYER latest transaction was an Informative Sell of $491.38K.
What was ANDREW S BOYER's most profitable transaction?
ANDREW S BOYER’s most profitable transaction was an Informative Buy of AMRX stock on August 7, 2019. The return on the trade was 51.50%.
What is ANDREW S BOYER's role in Amneal Pharmaceuticals?
ANDREW S BOYER's role in Amneal Pharmaceuticals is EVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.